Joseph Maakaron

1.5k total citations
65 papers, 465 citations indexed

About

Joseph Maakaron is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Joseph Maakaron has authored 65 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Hematology and 19 papers in Genetics. Recurrent topics in Joseph Maakaron's work include CAR-T cell therapy research (23 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Joseph Maakaron is often cited by papers focused on CAR-T cell therapy research (23 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Joseph Maakaron collaborates with scholars based in United States, Lebanon and Australia. Joseph Maakaron's co-authors include Veronika Bachanová, Alì Taher, Alice S. Mims, Aimee Merino, Najla El Jurdi, Houssam Halawi, Atallah Baydoun, Samantha Jaglowski, Jeffrey S. Miller and Basem M. William and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joseph Maakaron

57 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Maakaron United States 12 251 139 126 79 73 65 465
Folashade Otegbeye United States 10 316 1.3× 239 1.7× 135 1.1× 126 1.6× 37 0.5× 57 517
Masatoshi Sakurai Japan 13 118 0.5× 64 0.5× 204 1.6× 105 1.3× 114 1.6× 69 497
Muhammad Husnain United States 11 235 0.9× 70 0.5× 73 0.6× 88 1.1× 41 0.6× 69 467
Eiko Hayase Japan 13 162 0.6× 121 0.9× 169 1.3× 177 2.2× 22 0.3× 31 502
Ivan Moiseev Russia 13 209 0.8× 143 1.0× 336 2.7× 84 1.1× 93 1.3× 149 611
Tommaso Stefanelli Italy 7 93 0.4× 161 1.2× 259 2.1× 63 0.8× 97 1.3× 24 490
Elise McCormack United States 4 351 1.4× 137 1.0× 91 0.7× 118 1.5× 79 1.1× 8 565
Leyla Shune United States 13 410 1.6× 99 0.7× 343 2.7× 210 2.7× 90 1.2× 107 688
Tanja Kaartinen Finland 9 111 0.4× 113 0.8× 46 0.4× 77 1.0× 107 1.5× 17 494
Xia Mao China 16 512 2.0× 180 1.3× 194 1.5× 235 3.0× 53 0.7× 66 741

Countries citing papers authored by Joseph Maakaron

Since Specialization
Citations

This map shows the geographic impact of Joseph Maakaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Maakaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Maakaron more than expected).

Fields of papers citing papers by Joseph Maakaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Maakaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Maakaron. The network helps show where Joseph Maakaron may publish in the future.

Co-authorship network of co-authors of Joseph Maakaron

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Maakaron. A scholar is included among the top collaborators of Joseph Maakaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Maakaron. Joseph Maakaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Qing, Fiona He, Angela Krämer, et al.. (2024). The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical Outcomes. Transplantation and Cellular Therapy. 30(9). 919.e1–919.e9. 1 indexed citations
2.
3.
Finger, Erik B., Joseph Maakaron, Joseph Sushil Rao, et al.. (2024). Posttransplant Lymphoproliferative Disease Following Pancreas Transplantation: A 40 Year Single‐Center Experience. Clinical Transplantation. 38(8). e15386–e15386.
4.
Pophali, Priyanka A., Joshua Fein, Kwang Woo Ahn, et al.. (2024). CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma. Blood Advances. 8(20). 5290–5296. 6 indexed citations
5.
6.
Maakaron, Joseph, et al.. (2024). De novo Light Chain Deposition Disease in a Kidney Allograft: A Case Report and Literature Review. ˜The œNephron journals/Nephron journals. 149(5). 277–282.
7.
Merino, Aimee, Ryan Shanley, Veronika Bachanová, et al.. (2024). N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial. Transplantation and Cellular Therapy. 30(12). 1206.e1–1206.e12. 2 indexed citations
8.
Cao, Qing, Mark Juckett, Brian C. Betts, et al.. (2023). Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(4). 263.e1–263.e7. 7 indexed citations
9.
Maakaron, Joseph, et al.. (2023). Validation of Nivestym compared to Neupogen: An NMDP analysis. Journal of Clinical Apheresis. 39(1). e22097–e22097. 1 indexed citations
10.
Maakaron, Joseph & Basem M. William. (2023). Age is No Barrier: CAR-T Therapy in Older Adults. Drugs & Aging. 40(8). 685–689. 1 indexed citations
11.
Bohn, Bruno, Christopher Staley, Shernan G. Holtan, et al.. (2023). Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor. BMC Microbiology. 23(1). 258–258. 2 indexed citations
12.
Bachanová, Veronika, J. Žák, Qing Cao, et al.. (2023). Phase 1 trial of Ruxolitinib combined with Nivolumab in patients relapsed/refractory Hodgkin lymphoma after failure of check‐point inhibitor (CPI). Hematological Oncology. 41(S2). 582–582. 3 indexed citations
13.
Cao, Qing, Mark Juckett, Brian C. Betts, et al.. (2022). Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S424–S425.
14.
15.
Schaefer, Andrew, Ying Huang, Adam S. Kittai, et al.. (2021). Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience. Cancer Management and Research. Volume 13. 8901–8906. 17 indexed citations
16.
Huang, Ying, James S. Blachly, Nicole R. Grieselhuber, et al.. (2020). The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent. Clinical Lymphoma Myeloma & Leukemia. 21(1). e76–e83. 4 indexed citations
17.
Maakaron, Joseph, Zeinab El Boghdadly, Ying Huang, et al.. (2020). Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look. Biology of Blood and Marrow Transplantation. 26(8). e198–e201. 13 indexed citations
18.
Jurdi, Najla El, John Rogosheske, Ryan Shanley, et al.. (2020). Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma. Transplantation and Cellular Therapy. 27(2). 179.e1–179.e4. 2 indexed citations
19.
Maakaron, Joseph, Cappellini, & Alì Taher. (2013). An update on thalassemia intermedia. Scopus. 2 indexed citations
20.
Baydoun, Atallah, et al.. (2012). Hematological manifestations of celiac disease. Scandinavian Journal of Gastroenterology. 47(12). 1401–1411. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Folashade Otegbeye Breakdown of academic impact, for papers by Masatoshi Sakurai Breakdown of academic impact, for papers by Muhammad Husnain Breakdown of academic impact, for papers by Eiko Hayase Breakdown of academic impact, for papers by Ivan Moiseev Breakdown of academic impact, for papers by Tommaso Stefanelli Breakdown of academic impact, for papers by Elise McCormack Breakdown of academic impact, for papers by Leyla Shune Breakdown of academic impact, for papers by Tanja Kaartinen Breakdown of academic impact, for papers by Xia Mao
Rankless by CCL
2026